Filing Details
- Accession Number:
- 0001181431-12-064664
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-14 08:12:10
- Reporting Period:
- 2012-12-12
- Filing Date:
- 2012-12-14
- Accepted Time:
- 2012-12-14 08:12:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1325879 | Aveo Pharmaceuticals Inc | AVEO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1021038 | A Henri Termeer | C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-12-12 | 39,301 | $6.59 | 39,301 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2012-12-13 | 5,200 | $6.65 | 44,501 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $6.525 to $6.56. The reporting person undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $6.635 to $6.65. The reporting person undertakes to provide, upon request, to the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
